Biddle Warner Weston bought KYTX

March 13, 2026 · Form 4 insider transaction

Biddle Warner Weston bought 350,000 shares of Kyverna Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
350,000
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 13, 2026
Filing dateMarch 17, 2026
Shares owned after350,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

View the original Form 4 on SEC EDGAR